# Prefrontal Cortex Dysfunction as a Precipitating Factor for Schizophrenia and Depression

**Authors:** Daniela L. Uliana, Anthony A. Grace

PMC · DOI: 10.1111/jnc.70409 · 2026-03-10

## TL;DR

The prefrontal cortex's dysfunction during development can lead to depression and schizophrenia by disrupting stress regulation and dopamine balance.

## Contribution

The paper proposes that PFC dysfunction during adolescence and adulthood leads to distinct neurobiological pathways for depression and schizophrenia.

## Key findings

- PFC hypofunction in adulthood leads to hypodopaminergic states and amotivation in depression.
- Adolescent stress causes PV interneuron loss and hyperdopaminergic states linked to schizophrenia symptoms.
- PFC-amygdala circuit dysfunctions are identified as potential targets for early intervention.

## Abstract

The prefrontal cortex (PFC) is critical for regulating stress responses through top‐down control over limbic and subcortical structures. The PFC undergoes a prolonged developmental process that only reaches maturation during adulthood, causing it to be highly sensitive to environmental insults during neurodevelopment, such as adolescence. During this critical period, synaptic pruning, the maturation of inhibitory GABAergic interneurons, and the refinement of dopaminergic transmission collectively establish the excitatory‐inhibitory balance necessary for adaptive behavior. Impairment of the PFC due to developmental disruptions increases susceptibility to maladaptive stress responses. These responses can, in turn, contribute to the development of major depressive disorder and schizophrenia. In depression, a dysfunctional PFC fails to effectively inhibit the amygdala, which contributes to hyperactivity in stress‐related circuits, hypodopaminergic states, and anhedonia. In schizophrenia, a neurodevelopmental PFC dysfunction would precipitate hippocampal circuit disruption driven by stress. The inability of an immature PFC to regulate the amygdala response to stress would trigger an increased excitatory drive to the ventral hippocampus, which is proposed to underlie the excessive limbic drive, hippocampal hyperactivity, and a hyperdopaminergic state. In addition, the activation of the mesocortical dopaminergic system by stress facilitates the PFC response to stress, both during adulthood and adolescence. A dopamine (DA)‐induced unregulated stress response disrupts the excitatory and inhibitory transmission within the PFC, which plays a critical role in its function. Understanding the interplay between stress and PFC activity/maturation to regulate the circuit toward adaptive or maladaptive outcomes offers critical insights for early intervention and prevention. Early changes in the PFC could underlie vulnerability to unregulated stress response and its consequent effect in contributing to schizophrenia and depression. In this way, early intervention may limit the impact and prevent further circuit dysregulation leading to pathological states.

Stress during adolescence or adulthood affects the ability of the prefrontal cortex (PFC) to adaptively regulate stress. Maladaptive adult stress leads to PFC hypofunction and a hypodopaminergic state in the medial, affect‐related ventral tegmental area (VTA), resulting in amotivation. Stress during adolescence triggers parvalbumin (PV) interneuron loss in the ventral hippocampus due to the inability of an immature PFC to regulate stress; this leads to a hyperdopaminergic state in the associative striatal‐projecting lateral VTA that is proposed to underlie positive symptoms. These reveal neurobiological trajectories for psychiatric disorders, pinpointing PFC‐amygdala circuit dysfunctions as potential targets for interventions.

## Linked entities

- **Diseases:** depression (MONDO:0002050), schizophrenia (MONDO:0005090)

## Full-text entities

- **Genes:** SLC6A2 (solute carrier family 6 member 2) [NCBI Gene 6530] {aka NAT1, NET, NET1, SLC6A5}, Pvalb (parvalbumin) [NCBI Gene 25269] {aka PALB1, Pva}, SST (somatostatin) [NCBI Gene 6750] {aka SMST, SST1}, SLC6A3 (solute carrier family 6 member 3) [NCBI Gene 6531] {aka DAT, DAT1, PKDYS, PKDYS1}, TH (tyrosine hydroxylase) [NCBI Gene 7054] {aka DYT14, DYT5b, TYH}, PNN (pinin, desmosome associated protein) [NCBI Gene 5411] {aka DRS, DRSP, SDK3, memA}, PVALB (parvalbumin) [NCBI Gene 5816] {aka D22S749}
- **Diseases:** impairments in working memory (MESH:D008569), neuropathological (MESH:D009422), Cognitive impairment (MESH:D003072), neurodevelopmental disorder (MESH:D002658), blunted emotion (MESH:D014949), hippocampus dysfunction (MESH:D006331), Depression (MESH:D003866), neuronal loss (MESH:D009410), akathisia (MESH:D017109), attention deficits (MESH:D001289), psychosis (MESH:D011618), neurodevelopmental dysfunction (MESH:D065886), major (MESH:D004830), delusions (MESH:D063726), hallucinations (MESH:D006212), Amygdala hyperactivity (MESH:D006948), Major depressive disorder (MESH:D003865), emotional dysregulation (MESH:D021081), hyperprolactinemia (MESH:D006966), fatigue (MESH:D005221), affective disorders (MESH:D019964), anxiety (MESH:D001007), Schizophrenia (MESH:D012559), NMDA receptor hypofunction (MESH:D060426), drug abuse (MESH:D019966), Psychiatric (MESH:D001523), anhedonia (MESH:D059445), PFC abnormalities (MESH:C536329), D1 dysfunction (MESH:C567730), trauma (MESH:D014947), neurodegeneration (MESH:D019636)
- **Chemicals:** calcium (MESH:D002118), DA (MESH:D004298), fluorodopa (MESH:C043437), MAM (MESH:D008746), benzodiazepine (MESH:D001569), KarXT (-), amphetamine (MESH:D000661), GABA (MESH:D005680), NMDA (MESH:D016202), Acetylcholine (MESH:D000109), diazepam (MESH:D003975)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rodentia (rodent, order) [taxon 9989], Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12976470/full.md

---
Source: https://tomesphere.com/paper/PMC12976470